SANA
Price
$3.31
Change
-$0.04 (-1.19%)
Updated
Jun 23, 04:17 PM (EDT)
Capitalization
935.06M
37 days until earnings call
Intraday BUY SELL Signals
TCRX
Price
$0.93
Change
+$0.06 (+6.90%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
56.9M
57 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SANA vs TCRX

SANA vs TCRX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
SANA vs. TCRX commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SANA is a Buy and TCRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (SANA: $3.36 vs. TCRX: $0.87)
Brand notoriety: SANA and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SANA: 95% vs. TCRX: 230%
Market capitalization -- SANA: $935.06M vs. TCRX: $56.9M
SANA [@Biotechnology] is valued at $935.06M. TCRX’s [@Biotechnology] market capitalization is $56.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SANA’s FA Score shows that 0 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • SANA’s FA Score: 0 green, 5 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, both SANA and TCRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SANA’s TA Score shows that 5 TA indicator(s) are bullish while TCRX’s TA Score has 4 bullish TA indicator(s).

  • SANA’s TA Score: 5 bullish, 5 bearish.
  • TCRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both SANA and TCRX are a good buy in the short-term.

Price Growth

SANA (@Biotechnology) experienced а +17.89% price change this week, while TCRX (@Biotechnology) price change was -8.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

SANA is expected to report earnings on Jul 30, 2026.

TCRX is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SANA($935M) has a higher market cap than TCRX($56.9M). TCRX YTD gains are higher at: -12.930 vs. SANA (-17.445). TCRX has higher annual earnings (EBITDA): -118.65M vs. SANA (-192.2M). TCRX has more cash in the bank: 128M vs. SANA (101M). SANA has less debt than TCRX: SANA (75.3M) vs TCRX (92.5M). TCRX has higher revenues than SANA: TCRX (9.14M) vs SANA (0).
SANATCRXSANA / TCRX
Capitalization935M56.9M1,643%
EBITDA-192.2M-118.65M162%
Gain YTD-17.445-12.930135%
P/E RatioN/AN/A-
Revenue09.14M-
Total Cash101M128M79%
Total Debt75.3M92.5M81%
TECHNICAL ANALYSIS
Technical Analysis
SANATCRX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
SANA
Daily Signal:
Gain/Loss:
TCRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NRECX15.160.20
+1.37%
Neuberger Real Estate C
VCRQX16.050.08
+0.50%
NYLI CBRE Global Infrastructure Class R6
ASQAX20.87N/A
N/A
American Century Small Company A
TILPX30.49N/A
N/A
Nuveen Large Cap Growth Premier
EMQAX10.87N/A
N/A
Ashmore Emerging Markets Active Eq A

SANA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SANA has been loosely correlated with CRBU. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if SANA jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SANA
1D Price
Change %
SANA100%
+6.67%
CRBU - SANA
53%
Loosely correlated
+0.18%
ABSI - SANA
48%
Loosely correlated
+13.50%
RXRX - SANA
48%
Loosely correlated
-2.01%
EDIT - SANA
47%
Loosely correlated
+3.53%
VIR - SANA
47%
Loosely correlated
+4.48%
More